Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

COVID-19 Trusted Evidence 

The Centre for Evidence-Based Medicine (CEBM) have established the Oxford COVID-19 Evidence Service and we are also supporting the COVID-19 RCGP Scientific Steering Committee.

These rapid systematic review services have gained rapid adoption with over 2 million views for the Evidence Service in its first 10 days, and had in excess of 70 reviews developed an published during April alone.

The Evidence Service is now recognised as having ‘a lasting research value’ by the Oxford University Bodleian Library and worthy of permanent preservation in their web archive.

Further Information:

www.cebm.net/covid-19

COVID-19 and cystic fibrosis rapid guideline
(NG170)

Professor John Powell, Digital health theme lead, is a consultant clinical adviser at NICE, and has been supporting the NICE rapid COVID-19 guidelines programme. For example he was the lead NICE clinical adviser on the COVID-19 and cystic fibrosis rapid guideline (NG170).

Further information:

www.nice.org.uk/guidance/ng170

Managing suspected or confirmed pneumonia in adults in the community (NG165)

Professors Richard Hobbs, Trisha Greenhalgh and Carl Henegan also played a key role in developing rapid NICE guidance on managing suspected or confirmed pneumonia in adults in the community during the COVID-19 pandemic.

Further information:

www.nice.org.uk/guidance/ng165/chapter/2-Treatment-and-care-planning

Direct staff responses

Bethan McDonald, ARC Partner Manager and public health specialist, is supporting the Thames Valley Public Health England health protection team in its response.

This involves providing public health advice, guidance and management support to providers across the Thames Valley. We are working mainly with primary care, secondary care, laboratories, care homes, prisons, schools and local authorities – providing risk assessments of outbreaks and guidance on control and management. 

Further information: 

www.gov.uk/government/organisations/public-health-england

Recent ARC OxTV news

New study shows potential link between bodyweight and risk of severe COVID-19, especially for younger adults

The first large study to report the effect of bodyweight on risk of worse outcomes from COVID-19 across the full range of body mass index (BMI) is published today in The Lancet Diabetes and Endocrinology journal.

New clinical prediction tools for myeloma

New research, that further develops findings from CLAHRC Oxford supported research, has led to the development of new clinical prediction models for myeloma that incorporate both symptoms and blood test results.